These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome. Ohwada C, Nakaseko C, Sakai S, Takeda Y, Abe D, Takeuchi M, Sakaida E, Masuda S, Shimizu N, Cho R, Nishimura M, Kanai K, Misawa S, Kuwabara S. Bone Marrow Transplant; 2009 May; 43(9):739-40. PubMed ID: 19043459 [No Abstract] [Full Text] [Related]
18. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study. Misawa S, Sato Y, Katayama K, Hanaoka H, Sawai S, Beppu M, Nomura F, Shibuya K, Sekiguchi Y, Iwai Y, Watanabe K, Amino H, Ohwada C, Takeuchi M, Sakaida E, Nakaseko C, Kuwabara S. BMJ Open; 2015 Nov 11; 5(11):e009157. PubMed ID: 26560063 [Abstract] [Full Text] [Related]
19. Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome. Autore F, Innocenti I, Luigetti M, Piccirillo N, Sora F, Chiusolo P, Sica S, Bacigalupo A, Laurenti L. Hematol Oncol; 2018 Apr 11; 36(2):392-398. PubMed ID: 28913957 [Abstract] [Full Text] [Related]
20. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome. Kanai K, Kuwabara S, Misawa S, Hattori T. Intern Med; 2007 Apr 11; 46(6):311-3. PubMed ID: 17380000 [Abstract] [Full Text] [Related] Page: [Next] [New Search]